| Old Articles: <Older 1091-1100 Newer> |
|---|
 |
Bio-IT World
Jul/Aug 2006
Kate McDonald |
The Next Generation in Sequencing Is SOLiD Applied Biosystems has completed the acquisition of genetic analysis company Agencourt Personal Genomics for $120 million, and hopes to bring the company's novel next-generation sequencing technology to market next year.   |
Bio-IT World
Jul/Aug 2006
Robert M. Frederickson |
Tests for Hospital-Acquired Infections Tests for pathogens increasingly rely on genomic methods that identify specific genetic signatures of bacteria or viruses. Rapid detection of other pathogens also provides the potential for significant impact on the healthcare industry. |
Bio-IT World
Jul/Aug 2006 |
News Blast Health Solutions... Rna Interference... HIV Triple Combo... |
Bio-IT World
Jul/Aug 2006 |
New Products Automating ELISA with Ease... deltaDOT Marks the Spot with Sequencer... The Power of Mass, Size, and Shape... Smaller Fits Better with SciGene's Incubation System... |
Bio-IT World
Jul/Aug 2006
Salvatore Salamone |
The Uncommon Information Commons Work with MAYA Design has led to the development of what is being called the Genetic Information Commons, a peer-to-peer system that allows many people to securely post and share large amounts of disparate data. |
Bio-IT World
Jul/Aug 2006
Nosa Omoigui |
Going Beyond Search for the Enterprise Beyond standard search, technology exists to bring knowledge discovery to the desktops of life science workers. Understanding the difference between standard search retrieval and true knowledge discovery is an important step in helping knowledge workers gain insight and grapple with larger universal health and medical issues. |
Bio-IT World
Jul/Aug 2006
John Russell |
MathWorks Launches a 'Systems Biology' Tool The maker of the popular MATLAB programming environment recently launched a modeling product, SimBiology, aimed at systems biology and synthetic biology markets. |
Bio-IT World
Jul/Aug 2006
John Russell |
Mastering the Art of QSAR Quantitative structure activity/property relationship modeling approaches to drug design are hardly new, and increasing experience with them along with readily available computing power has expanded their use. Yet QSAR-based models remain problematic and are often poorly predictive. |
Bio-IT World
Jul/Aug 2006
Eric K. Neumann |
Combining Drug Toxicity Knowledge Nearly half the drugs entering clinical trials will fail because of some form of serious toxicity that was missed in preclinical studies. These failures should not happen at such a late stage in the process. So what can be done? |
Chemistry World
August 3, 2006
Bea Perks |
Sugar-Coated Antibodies The fate of the prey captured by our body's guardian antibodies can be determined by sugar molecules found on the antibody's surface. The news has come as a surprise to immunologists, who were unsure of these sugar molecules' exact role. |
| <Older 1091-1100 Newer> Return to current articles. |
